Warning Letters Are Not Final Actions, Court Rules

The U.S. Court of Appeals for the District of Columbia has reaffirmed a lower court decision that FDA warning letters are not final agency actions, so companies cannot seek judicial review of them under the Administrative Procedures Act.
Drug Industry Daily